Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Precipio, Inc.

Market Cap 3.94Cr 3.41Cr 3.14Cr 2.94Cr 5.51Cr 374.92Cr 5.59Cr 37Cr 14Cr 182.49Cr 15Cr 14Cr 631.87Cr P/E Ratio 2024
-1.89x
P/E Ratio 2025 -102x
Enterprise Value 4.04Cr 3.49Cr 3.22Cr 3.01Cr 5.65Cr 384.45Cr 5.73Cr 38Cr 15Cr 187.13Cr 15Cr 15Cr 647.92Cr EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
88.19%
Yield 2024 *
-
Yield 2025 -
1 day-2.34%
1 week-5.92%
Current month-3.07%
1 month-22.94%
3 months-23.20%
6 months-11.49%
Current year-3.83%
1 week 21.9
Extreme 21.901
24.3
1 month 21.67
Extreme 21.67
29.7
Current year 19.52
Extreme 19.52
33.63
1 year 10.5
Extreme 10.5
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
93
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Executive Officer 54 28/06/2017
Director of Finance/CFO 59 21/03/2022
Chief Tech/Sci/R&D Officer 42 01/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap.
21/05Sell

Chairman

-900 0.0505%
20/05Sell

Chairman

-2,534 0.1421%
15/04Free

Director

365 0.0208%
Change 5-day change 1-year change 3-year change Capi.($)
-2.34%-5.92%+96.36%+146.93% 4.04Cr
+0.35%-2.32%+11.21%-31.46% 1.65TCr
-0.23%+0.92%+26.93%+67.98% 166.56Cr
-0.65%-0.90%-31.26%+17.62% 111.26Cr
+0.28%-1.40%-52.71%-83.22% 96Cr
+2.05%-2.67%-23.14%-53.53% 64Cr
+1.38%-3.99%-46.02%-57.96% 56Cr
+0.09%+9.42%+29.43%-51.79% 46Cr
-1.57%-4.56%-54.98%-62.49% 39Cr
-2.34%-5.65%+44.89% - 34Cr
Average -0.30%-0.48%+0.07%-11.99% 226.36Cr
Weighted average by Cap. +0.25%-1.57%+5.07%-25.75%

Financials

2024 2025
Net sales 1.85Cr 1.6Cr 1.47Cr 1.38Cr 2.59Cr 176.15Cr 2.63Cr 17Cr 6.79Cr 86Cr 6.96Cr 6.81Cr 296.87Cr 2.4Cr 2.08Cr 1.91Cr 1.79Cr 3.36Cr 228.59Cr 3.41Cr 23Cr 8.81Cr 111.26Cr 9.03Cr 8.83Cr 385.24Cr
Net income -42.9L -37.05L -34.14L -31.96L -59.9L -41Cr -60.82L -4.03Cr -1.57Cr -20Cr -1.61Cr -1.58Cr -69Cr -4L -3L -3L -3L -5L -3.45Cr -5L -34.11L -13.3L -1.68Cr -13.62L -13.33L -5.81Cr
Net Debt -1L -1L -1L -1L -2L -1.29Cr -2L -12.78L -5L -62.92L -5L -5L -2.18Cr 10.02L 9L 8L 7L 13.99L 9.52Cr 14.21L 94.17L 36.71L 4.64Cr 37.61L 36.8L 16Cr
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
12/26/12 22.10 $ -2.34% 24,756
11/26/11 22.63 $ +0.35% 12,300
10/26/10 22.55 $ -3.30% 13,134
09/26/09 23.32 $ +1.39% 24,762
08/26/08 23.00 $ -2.09% 39,317
  1. Stock Market
  2. Stocks
  3. PRPO Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!